Basic Information | Post buying leads | Suppliers | Cas Database |
Name |
Salicylhydroxamic acid |
EINECS | 201-934-3 | |
CAS No. | 89-73-6 | Density | 1.402g/cm3 | |
PSA | 69.56000 | LogP | 0.90210 | |
Solubility | soluble | Melting Point |
175 - 178 C
|
|
Formula | C7H7 N O3 | Boiling Point | 389.7°C at 760 mmHg | |
Molecular Weight | 153.137 | Flash Point | 248.9oC | |
Transport Information | OTH | Appearance | brownish crystalline powder | |
Safety | Moderately toxic by intraperitoneal route. Mutation data reported. Used as a pharmaceutical and veterinary drug. When heated to decomposition it emits toxic fumes of NOx. | Risk Codes | R40 | |
Molecular Structure | Hazard Symbols | |||
Synonyms |
Salicylohydroxamicacid (6CI,7CI,8CI); 2-Hydroxybenzenehydroxamic acid; 2-Hydroxybenzohydroxamicacid; 2-Hydroxyphenylhydroxamic acid; N,2-Dihydroxybenzamide;N-Salicylhydroxamic acid; NSC 193440; NSC 5088; SHA; SHAM; Salicylhydroxamicacid; o-Hydroxybenzohydroxamic acid |
Article Data | 32 |
Molecular Formula: C7H7NO3
Molar mass: 153.14 g/mol
EINECS: 201-934-3
Density: 1.402 g/cm3
Flash Point: 248.9 °C
Index of Refraction: 1.626
Boiling Point: 389.7 °C at 760 mmHg
Vapour Pressure: 9.01E-07 mmHg at 25°C
Melting point: 177 °C (dec.)(lit.)
Appearance: Off-white powder
Product categories of Salicylhydroxamic acid (89-73-6): Aromatic Hydrazides, Hydrazines, Hydrazones and Oximes;Hydroxylamines
Structure of Salicylhydroxamic acid (89-73-6):
XLogP3-AA: 0.9
H-Bond Donor: 3
H-Bond Acceptor: 3
Systematic Name: 2-Hydroxybenzenecarbohydroxamic acid
SMILES: O=C(c1ccccc1O)NO
InChI: InChI=1/C7H7NO3/c9-6-4-2-1-3-5(6)7(10)8-11/h1-4,9,11H,(H,8,10)
InChIKey: HBROZNQEVUILML-UHFFFAOYAX
Std. InChI: InChI=1S/C7H7NO3/c9-6-4-2-1-3-5(6)7(10)8-11/h1-4,9,11H,(H,8,10)
Std. InChIKey: HBROZNQEVUILML-UHFFFAOYSA-N
Salicylhydroxamic acid (89-73-6) can be used for pharmaceutical intermediate.It also can be used as hemical analysis reagents of bismuth, copper, nickel and copper.
Salicylhydroxamic acid (89-73-6) cand be derived from the o-Hydroxybenzoate sodium hydroxide and Hydrochloric acid in the presence of Hydroxylamine condensation by acidification .
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
mouse | LD50 | intraperitoneal | 860mg/kg (860mg/kg) | National Cancer Institute Screening Program Data Summary, Developmental Therapeutics Program. Vol. JAN1986, | |
rat | LD50 | intraperitoneal | 600ug/kg (0.6mg/kg) | Toxicology Letters. Vol. (Suppl), Pg. 247, 1992. | |
rat | LD50 | oral | 5gm/kg (5000mg/kg) | Toxicology Letters. Vol. (Suppl), Pg. 247, 1992. |
EPA Genetic Toxicology Program.
Moderately toxic by intraperitoneal route. Mutation data reported. Used as a pharmaceutical and veterinary drug. When heated to decomposition it emits toxic fumes of NOx.
Hazard Codes: Xn
Risk Statements:
20: Harmful by inhalation
21: Harmful in contact with skin
22: Harmful if swallowed
36: Irritating to the eyes
37: Irritating to the respiratory system
38: Irritating to the skin
40: Limited evidence of a carcinogenic effect
Safety Statements:
22: Do not breathe dust
24: Avoid contact with skin
25: Avoid contact with eyes
26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice
36: Wear suitable protective clothing
Salicylhydroxamic acid (89-73-6) also can be called SHAM ; Salicylhydroxamate ; Saliaylhydroxamic acid ; 2-Hydroxybenzohydroxamic acid and Benzamide, N,2-dihydroxy- .